- জেনেরিক নাম
- Pioglitazone
- শক্তি
- 15 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- The ACME Laboratories Ltd.
৳ ৮.০৭ প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
বাংলাদেশে Pidus 15 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Pioglitazone আছে (১৫ mg)। Pidus-এর প্রতি ইউনিটের দাম ৮.০৭ টাকা। Pioglitazone-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এটি তৈরি করে The ACME Laboratories Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Pioglitazone-এর ১২টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ৭টি। সবচেয়ে কম দাম Pioglinet 15 mg Tablet-এর, প্রতি ইউনিট ৳ ১।
Pidus 15 mg Tablet from The ACME Laboratories Ltd. contains pioglitazone, a thiazolidinedione group oral antidiabetic medicine. It is used as an adjunct to diet and exercise to improve blood sugar control in people with type II diabetes. It works by reducing insulin resistance in the body and the liver, and it needs the presence of insulin to act. It can be used alone or in combination with other diabetes medicines such as a sulphonylurea, metformin or insulin when diet, exercise and a single agent do not control blood sugar well. The doctor decides whether it suits a particular person.
Pidus 15 mg Tablet is used as an add-on to diet and exercise to improve blood sugar control in type II diabetes. It may be prescribed alone, or together with a sulphonylurea, metformin or insulin when diet, exercise and one medicine do not give adequate control. Because it works only when insulin is present, it is not meant for type 1 diabetes or for diabetic ketoacidosis. Your doctor will decide if it is appropriate for your situation.
Pidus 15 mg Tablet is taken by mouth. The doctor decides the dose and how long the course should continue; do not change the amount or stop it on your own. The tablet can generally be taken without regard to meals. If you also use other diabetes medicines, follow the instructions your doctor gives for each one. Ask your doctor or pharmacist if you are unsure how to take it, and tell them about any other medicines you use.
In placebo-controlled trials of pioglitazone, the more commonly reported events included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat. Not everyone gets these, and this is not a complete list. If you notice a side effect that bothers you, or if you are worried about any symptom, speak to your doctor or pharmacist. Seek medical help if a symptom is severe or does not settle.
Pidus 15 mg Tablet is not for people with a known hypersensitivity to pioglitazone or any of its ingredients. It should not be used in type 1 diabetes or for diabetic ketoacidosis. Use with caution when it is combined with other antidiabetic therapy, and in hepatic insufficiency; liver enzymes should be monitored regularly. There are no adequate and well-controlled studies in pregnant women, so it should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus. It is not known whether it passes into human milk, and it should not be given to a breastfeeding woman. Ask your doctor before starting it if you are pregnant, breastfeeding, or have liver problems.
The listed price is ৳ ৮.০৭.
It is taken by mouth. The doctor decides the dose and how long you should take it, so follow their instructions and do not change the amount yourself. It can generally be taken without regard to meals. Ask your doctor or pharmacist if anything is unclear.
Do not use it if you are hypersensitive to pioglitazone or any ingredient. It is not for type 1 diabetes or diabetic ketoacidosis. Ask your doctor first if you are pregnant, breastfeeding, have liver problems, or use other diabetes medicines, as caution and monitoring may be needed.
Reported events in trials included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat. This is not a complete list. If any symptom is severe, does not settle, or worries you, contact your doctor or pharmacist for advice.
৳ ৮.০৭ প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pioglitazone is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Pioglitazone is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pioglitazone is a preparation of Pioglitazone which is a member of the newest class of oral antidiabetic agent called thiazolidinediones. It depends on the presence of Insulin for its mechanism of action. Pioglitazone decreases Insulin resistance in the periphery and in the liver, resulting in increased Insulin dependent glucose disposal and decreased hepatic glucose output. It also improves abnormality in lipid metabolism by activating peroxisome proliferator activated receptor gamma (PPAR-γ).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pioglitazone can be taken once daily without regard to meals. The management of antidiabetic therapy should be individualized. Pioglitazone monotherapy may be initiated at 15 mg or 30 mg once daily dosages in patients not adequately controlled with diet and exercise alone. For patients who respond inadequately to the initial dose of Pioglitazone, the dose can be increased up to 45 mg once daily. For patients not responding adequately to monotherapy, combination therapy should be considered.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Administration of thiazolidinediones with an oral contraceptive containing ethinyl oestradiol and norethindrone reduces the plasma concentration of both hormones by approximately 30% which could result in loss of contraception.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pioglitazone is contraindicated in patients with known hypersensitivity to any of its components.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The overall incidence and types of adverse events reported in placebo controlled clinical trials of Pioglitazone monotherapy at doses of 7.5 mg, 15 mg, 30 mg or 45 mg once daily are upper respiratory tract infection (13.2%), headache (9.1%), sinusitis (6.3%), myalgia (5.4%), tooth disorder (5.3%), and pharyngitis (5.1%).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: There are no adequate and well controlled studies in pregnant women. Pioglitazone should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pioglitazone exerts its antihyperglycaemic effect only in the presence of Insulin. Therefore, it should not be used in Type 1 diabetes or for the treatment of diabetic ketoacidosis. Pioglitazone should be used with caution in case of combination antidiabetic therapy and hepatic insufficiency. Liver enzyme should be monitored regularly.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।